TLSI – trisalus life sciences, inc. (US:NASDAQ)
Stock Stats
News
TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models
Canaccord Lowers its Price Target on TriSalus Life Sciences, Inc. (TLSI) to $7 from $12 and Maintains a Buy Rating [Yahoo! Finance]
TriSalus Life Sciences (TLSI) was upgraded by Wall Street Zen from "s
TriSalus Life Sciences (TLSI) had its price target lowered by Canaccord Genuity Group Inc. from $12.00 to $7.00. They now have a "buy" rating on the stock.
TriSalus Life Sciences Q4 Earnings Call Highlights [Yahoo! Finance]
Form 4 TriSalus Life Sciences, For: Mar 11 Filed by: Devlin Jodi
Form 4 TriSalus Life Sciences, For: Mar 11 Filed by: Cox Bryan F.
Form 4 TriSalus Life Sciences, For: Mar 11 Filed by: Marshak Richard
Form 4 TriSalus Life Sciences, For: Mar 11 Filed by: Stevens Jennifer
Form 4 TriSalus Life Sciences, For: Mar 11 Filed by: Szela Mary T
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.